Robert W Yeh

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention
    Neil J Wimmer
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Am Heart Assoc 2:e000174. 2013
  2. doi request reprint Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention
    Robert W Yeh
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Circ Cardiovasc Interv 5:227-36. 2012
  3. doi request reprint Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention
    Robert W Yeh
    MSc, Cardiology Division, GRB 800, Massachusetts General Hospital, Boston, MA 02144
    Circulation 124:1557-64. 2011
  4. doi request reprint Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting
    Robert W Yeh
    Cardiology Division, GRB 800, Massachusetts General Hospital, Boston, MA 02144, USA
    Circulation 123:1384-90. 2011
  5. pmc Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study
    Robert W Yeh
    Cardiology Division, GRB800, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    BMC Med 9:78. 2011
  6. doi request reprint A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention
    Jason H Wasfy
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Circ Cardiovasc Qual Outcomes 6:429-35. 2013
  7. ncbi request reprint Analysis of cardiac dimensions, mass and function in heart transplant recipients using 64-slice multi-detector computed tomography
    Maros Ferencik
    Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Heart Lung Transplant 26:478-84. 2007
  8. ncbi request reprint Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography
    Taishi Yonetsu
    Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 110:933-9. 2012
  9. ncbi request reprint Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes
    Robert W Yeh
    Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    Catheter Cardiovasc Interv 74:359-64. 2009
  10. doi request reprint Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study
    Koji Kato
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    JACC Cardiovasc Interv 5:1150-8. 2012

Collaborators

Detail Information

Publications34

  1. pmc Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention
    Neil J Wimmer
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Am Heart Assoc 2:e000174. 2013
    ..We sought to develop a prediction model for access site complications in patients undergoing PCI with femoral arteriotomy, and assess whether transradial access was selectively used in patients at high risk for complications...
  2. doi request reprint Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention
    Robert W Yeh
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Circ Cardiovasc Interv 5:227-36. 2012
    ..Little is known about variation in the performance of hospitals on this measure, and whether high hospital rates of readmission after PCI are due to modifiable deficiencies in quality of care has not been assessed...
  3. doi request reprint Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention
    Robert W Yeh
    MSc, Cardiology Division, GRB 800, Massachusetts General Hospital, Boston, MA 02144
    Circulation 124:1557-64. 2011
    ..To assist physicians in targeting DES use in patients at the highest risk for target vessel revascularization (TVR), we developed and validated a model to predict TVR...
  4. doi request reprint Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting
    Robert W Yeh
    Cardiology Division, GRB 800, Massachusetts General Hospital, Boston, MA 02144, USA
    Circulation 123:1384-90. 2011
    ..Whether PMS studies are representative of carotid artery stenting in routine clinical practice has not been established...
  5. pmc Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study
    Robert W Yeh
    Cardiology Division, GRB800, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    BMC Med 9:78. 2011
    ..In order to explore reasons for this discrepancy, we compared outcomes after percutaneous coronary intervention (PCI) with DES or BMS by multiple statistical methods...
  6. doi request reprint A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention
    Jason H Wasfy
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Circ Cardiovasc Qual Outcomes 6:429-35. 2013
    ..We aimed to develop and validate prediction models to assist clinicians and hospitals in identifying patients at highest risk for 30-day readmission after PCI...
  7. ncbi request reprint Analysis of cardiac dimensions, mass and function in heart transplant recipients using 64-slice multi-detector computed tomography
    Maros Ferencik
    Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Heart Lung Transplant 26:478-84. 2007
    ..The aim of this study was to compare 64-slice MDCT analysis of cardiac structure and function to 2-dimensional echocardiography in heart transplant recipients...
  8. ncbi request reprint Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography
    Taishi Yonetsu
    Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 110:933-9. 2012
    ..In conclusion, lipid-rich neoatherosclerosis develops inside stents earlier in DESs than in BMSs. After 48 months, most restenotic stents will have developed lipid-laden neointima in both groups...
  9. ncbi request reprint Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes
    Robert W Yeh
    Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    Catheter Cardiovasc Interv 74:359-64. 2009
    ..This study examined the efficacy and safety of the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes undergoing cardiac catheterization...
  10. doi request reprint Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study
    Koji Kato
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    JACC Cardiovasc Interv 5:1150-8. 2012
    ..The aim of the present study was to compare the characteristics of nonculprit coronary plaques between diabetes mellitus (DM) and non-DM patients using 3-vessel optical coherence tomography (OCT) imaging...
  11. doi request reprint Pre-procedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE Registry
    Beau M Hawkins
    Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Am Coll Cardiol 60:1617-22. 2012
    ..We developed and internally validated a risk score to predict in-hospital stroke or death after carotid artery stenting (CAS)...
  12. pmc A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients
    Sahir Kalim
    Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
    J Am Heart Assoc 2:e000542. 2013
    ..The marked excess in cardiovascular mortality that results from uremia remains poorly understood...
  13. doi request reprint What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
    Ignacio Cruz-Gonzalez
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School Boston, Massachusetts, USA
    Blood Coagul Fibrinolysis 19:401-4. 2008
    ..006). These results suggest that in patients undergoing percutaneous coronary intervention, argatroban provides adequate anticoagulation with a low bleeding rate, when activated clotting time is maintained below 450 s...
  14. doi request reprint Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice
    Amit P Amin
    Cardiovascular Division, Department of Medicine, Barnes Jewish Hospital, Washington University School of Medicine, St Louis, Missouri, USA
    Arch Intern Med 172:1145-52. 2012
    ..Our objective was to assess whether DES are preferentially used in patients with higher predicted TVR risk and to estimate if lower use of DES in low-TVR-risk patients would be more cost-effective than the existing DES use pattern...
  15. ncbi request reprint Reporting trends and outcomes in ST-segment-elevation myocardial infarction national hospital quality assessment programs
    James M McCabe
    Division of Cardiology, University of Washington, Seattle J M M Division of Cardiology, St Luke s Mid America Heart Institute, Kansas City, MO K F K Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA A C E Division of Cardiology, North Shore Medical Center, Salem, MA H M W Department of Medicine E A M and Cardiology Division E P, R W Y, Massachusetts General Hospital, Boston and Division of Cardiovascular Medicine, Lahey Clinic Tufts Medical School, Burlington, MA F S R
    Circulation 129:194-202. 2014
    ..We sought to assess the use and impact of exclusion criteria associated with the CMS measure of door-to-balloon time in primary PCI...
  16. doi request reprint Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients
    Neil J Wimmer
    Brigham and Women s Hospital, and Harvard Medical School, 1620 Tremont Street, Boston, MA 02120, USA
    Stroke 43:3218-24. 2012
    ..The aim of this study was to predict individual patient risk after carotid artery stenting in patients at higher risk for carotid endarterectomy...
  17. doi request reprint Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period
    Joo Heung Yoon
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Bigelow 800, 55 Fruit Street, Boston, MA, 02114, USA
    J Thromb Thrombolysis 30:276-80. 2010
    ..In cardiac surgery patients with clinical suspicion of HIT, early postoperative use of argatroban seems well-tolerated and associated with a low risk of thrombotic events...
  18. ncbi request reprint Frequency of the use of low- versus high-dose aspirin in dual antiplatelet therapy after percutaneous coronary intervention (from the Dual Antiplatelet Therapy study)
    Alexis Matteau
    Brigham and Women s Hospital, Boston, Massachusetts
    Am J Cardiol 113:1146-52. 2014
    ..As HD ASA may be associated with adverse events in the setting of dual antiplatelet therapy, reducing local practice variation in the dose of ASA may be a target for quality improvement. ..
  19. doi request reprint Causes of short-term readmission after percutaneous coronary intervention
    Jason H Wasfy
    From the Cardiology Division J H W, C O B, R W Y, Department of Medicine J H W, C O B, R W Y, J B S, and Laboratory of Computer Science A H Z, J L, Massachusetts General Hospital, Harvard Medical School, Boston Saint Luke s Mid America Heart Institute UMKC, Kansas City, MO K F K, J A S Department of Biostatistics, Harvard School of Public Health, Boston, MA K Z, S L T N Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA L M and Harvard Clinical Research Institute, Boston, MA L M, R W Y
    Circ Cardiovasc Interv 7:97-103. 2014
    ..Rehospitalization within 30 days after an admission for percutaneous coronary intervention (PCI) is common, costly, and a future target for Medicare penalties. Causes of readmission after PCI are largely unknown...
  20. ncbi request reprint Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes
    Robert W Yeh
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    Am J Cardiol 100:1734-8. 2007
    ..In conclusion, thrombocytopenia is a significant correlate of adverse events in patients presenting with non-ST-elevation ACS treated with either enoxaparin or UFH...
  21. ncbi request reprint Population trends in the incidence and outcomes of acute myocardial infarction
    Robert W Yeh
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA
    N Engl J Med 362:2155-65. 2010
    ..Few studies have characterized recent population trends in the incidence and outcomes of myocardial infarction...
  22. pmc Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?
    Neil J Wimmer
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA
    Am Heart J 168:103-9. 2014
    ..We sought to quantify the delay in reperfusion from transradial PCI ("transradial delay") that would need to be introduced to offset the potential mortality benefit of transradial PCI, compared with transfemoral, observed in RCTs...
  23. doi request reprint Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study
    Koji Kato
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Circ Cardiovasc Imaging 5:433-40. 2012
    ..The aim of this study was to compare the plaque characteristics of nonculprit lesions between ACS and non-ACS patients using optical coherence tomography (OCT) imaging...
  24. ncbi request reprint Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease
    Suzanne J Baron
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Catheter Cardiovasc Interv 72:116-20. 2008
    ..This study aimed to evaluate the efficacy and safety of argatroban during percutaneous interventions for peripheral arterial disease (PAD)...
  25. ncbi request reprint Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention
    Neil J Wimmer
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02155, USA
    Trends Cardiovasc Med 22:23-8. 2012
    ....
  26. doi request reprint Instrumental variable analysis to compare effectiveness of stents in the extremely elderly
    Robert W Yeh
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA
    Circ Cardiovasc Qual Outcomes 7:118-24. 2014
    ..Instrumental variable methods identify variables associated with treatment allocation to perform adjusted comparisons that may overcome limitations of more traditional approaches...
  27. pmc Model feedback in Bayesian propensity score estimation
    Corwin M Zigler
    Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Biometrics 69:263-73. 2013
    ....
  28. pmc Geographic disparities in the incidence and outcomes of hospitalized myocardial infarction: does a rising tide lift all boats?
    Robert W Yeh
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
    Circ Cardiovasc Qual Outcomes 5:197-204. 2012
    ..However, no studies have examined regional differences in recent trends in MI incidence, and few have examined whether known regional disparities in MI care have narrowed over time...
  29. doi request reprint Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities
    Robert W Yeh
    Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Arch Intern Med 170:759-64. 2010
    ....
  30. doi request reprint Comparative effectiveness research: does one size fit all?
    Lauren M Kunz
    Department of Biostatistics, Harvard School of Public Health, Boston, MA, U S A
    Stat Med 31:3062-5; discussion 3066-7. 2012
    ..Observational studies should not be ruled out when designing studies to address questions of comparative effectiveness...
  31. pmc A combined epidemiologic and metabolomic approach improves CKD prediction
    Eugene P Rhee
    Nephrology Division, Massachusetts General Hospital, Boston, MA 02114, USA
    J Am Soc Nephrol 24:1330-8. 2013
    ..0001). Thus, the addition of metabolite profiling to clinical data may significantly improve the ability to predict whether an individual will develop CKD by identifying predictors of renal risk that are independent of estimated GFR. ..
  32. doi request reprint Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program
    Richard D Rothman
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, USA
    Am J Cardiol 110:1169-74. 2012
    ..7-year follow-up, obviating SRT in these patients. Clinicians in programs offering SRT should optimize conservative therapy before recommending SRT...
  33. ncbi request reprint Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome
    Ignacio Cruz-Gonzalez
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Gray Bigelow 800, 55 Fruit Street, Boston, MA 02114, USA
    J Thromb Thrombolysis 25:214-8. 2008
    ....
  34. ncbi request reprint Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy
    Shawn A Gregory
    Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 98:877-84. 2006
    ..Further, MDCT measurements of lumen diameters correlated well with quantitative coronary angiography...